The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...
About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...
CMS has identified 15 prescription drugs to target for lower prices in 2028: Anoro Ellipta, Biktarvy, Botox, Cimzia, Cosentyx, Entyvio, Erleada, Kisqali, Lenvima, Orencia, Rexulti, Trulicity, Verzenio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results